Premium
Screening decreases prostate cancer death: first analysis of the1988 Quebec Prospective Randomized Controlled Trial
Author(s) -
Barratt Alexandra L,
Coates Alan S
Publication year - 2004
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2004.tb06240.x
Subject(s) - officer , public health , test (biology) , medicine , family medicine , library science , randomized controlled trial , clinical trial , gerontology , political science , law , surgery , nursing , pathology , biology , paleontology , computer science
The Medical Journal of Australia ISSN: 0025729X 16 August 2004 181 4 213-214 ©The Medical Journal of Australia 2004 www.mja.com.au EBM: Trials on Trial Design: Randomised controlled trial. Setting: Population-based study in Quebec City, Canad Participants: 46 193 men aged 45–80 years registered o electoral roll of Quebec City and metropolitan area. Interventions: Invitation to attend annual PSA testing a rectal examination to screen for prostate cancer from N 1988 to December 1996. Trial: Labrie F, Candas B, Dupont A et al. Screening decreases prostate cancer death: first analysis of the 1988 Quebec Prospective Randomized Controlled Trial. Prostate 1999; 38: 83-91.